Cargando…
Feasibility of deep learning-based tumor segmentation for target delineation and response assessment in grade-4 glioma using multi-parametric MRI
BACKGROUND: Tumor burden assessment is essential for radiation therapy (RT), treatment response evaluation, and clinical decision-making. However, manual tumor delineation remains laborious and challenging due to radiological complexity. The objective of this study was to investigate the feasibility...
Autores principales: | Hannisdal, Marianne H, Goplen, Dorota, Alam, Saruar, Haasz, Judit, Oltedal, Leif, Rahman, Mohummad A, Rygh, Cecilie Brekke, Lie, Stein Atle, Lundervold, Arvid, Chekenya, Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10162115/ https://www.ncbi.nlm.nih.gov/pubmed/37152808 http://dx.doi.org/10.1093/noajnl/vdad037 |
Ejemplares similares
-
Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study
por: Rahman, Mohummad A., et al.
Publicado: (2020) -
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
por: Blakstad, Hanne, et al.
Publicado: (2023) -
P14.09 BORTEM-17: A Phase IB/II Single-Arm, Control Non-Randomized, Multicentre, Open Label Clinical Trial for Recurrent Glioblastoma with unmethylated MGMT promoter (NCT03643549)
por: Goplen, D, et al.
Publicado: (2021) -
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival
por: Rahman, Mohummad Aminur, et al.
Publicado: (2019) -
Dynamic Contrast Enhanced MRI Detects Early Response to Adoptive NK Cellular Immunotherapy Targeting the NG2 Proteoglycan in a Rat Model of Glioblastoma
por: Rygh, Cecilie Brekke, et al.
Publicado: (2014)